Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
29 studies found for:    " October 04, 2008":" November 03, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" October 04, 2008":" November 03, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Spatial Epidemiology of HIV Infection
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Intervention:
2 Active, not recruiting HIV Risk Reduction in Youth in the Bahamas
Condition: HIV Infections
Interventions: Behavioral: FOYC;   Behavioral: Goal for it (GFI);   Behavioral: Wonderous Wetlands;   Behavioral: Caribbean Informed Parents and Children Together (CImPACT);   Behavioral: Bahamian Focus on Older Youth (BFOOY);   Behavioral: Health and Family Life Curriculum (HFLE)
3 Completed Pilot Opened Trial in HIV-infected Patients Including an Investigational Marketed Product
Condition: HIV Infections
Interventions: Drug: raltegravir;   Drug: 1 P inhibitor + 2 nucleoside reverse transcriptase inhibitor or 1 non-nucleoside reverse transcriptase inhibitor + 2 nucleoside reverse transcriptase inhibitor
4 Enrolling by invitation Analysis of HIV-1 Replication During Antiretroviral Therapy
Condition: HIV Infection
Intervention:
5 Terminated
Has Results
Aspirin and Antiretroviral Therapy in HIV Infected Patients
Condition: HIV Infection
Interventions: Drug: Aspirin 325mg;   Drug: Antiretroviral therapy (ART)
6 Completed
Has Results
Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4+ T Cell Response
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Hyper-immune Bovine Colostrum;   Other: raltegravir placebo;   Other: Hyper-immune Bovine Colostrum placebo;   Drug: raltegravir and hyper-immune bovine colostrum
7 Completed Hepatitis B and HIV Co-Infection in Patients in Uganda
Conditions: Hepatitis B;   HIV Infections
Intervention:
8 Completed PENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV Infection
Condition: HIV Infection
Interventions: Biological: PENNVAX-B;   Biological: GENEVAX IL-12-4532;   Biological: PLACEBO;   Biological: IL-15 adjuvant
9 Completed Peripheral Reservoir of HIV DNA in Monocytes Pivotal to Cognition in HIV
Condition: HIV Infections
Intervention:
10 Completed HIV-1 Specific Immune Responses in Thai Individuals With HIV Dementia
Condition: HIV Infections
Intervention:
11 Terminated Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1
Condition: Human Immunodeficiency Virus
Interventions: Drug: 3-drug anti-HIV therapy;   Drug: Raltegravir
12 Terminated
Has Results
Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease
Condition: Acquired Immune Deficiency Syndrome
Interventions: Drug: Lopinavir 400 mg/ritonavir 100 mg;   Drug: Efavirenz
13 Withdrawn Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients
Conditions: Hepatitis B;   Human Immunodeficiency Virus;   Hepatitis C, Chronic
Interventions: Drug: maraviroc;   Drug: etravirine
14 Unknown  An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin
Conditions: HIV Infection;   Tuberculosis
Intervention: Drug: Rifampin
15 Recruiting Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults
Condition: HIV
Intervention:
16 Completed A Pilot Study to Characterize the Pharmacokinetics of Raltegravir in the Cervicovaginal Fluids of HIV-infected Women
Conditions: HIV;   AIDS
Intervention: Drug: Raltegravir (Isentress®)
17 Completed
Has Results
Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1
Condition: HIV
Intervention: Drug: Ibalizumab
18 Completed Case Management Alternatives for African American Women at High Risk for HIV
Condition: HIV
Intervention: Behavioral: strengths-based case management
19 Completed
Has Results
HIV Testing & Womens Attitudes on HIV Vaccine Trials
Condition: HIV
Intervention: Behavioral: Message Sidedness
20 Completed GSK1349572 Drug Interaction Study With Protease Inhibitors
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1349572

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Indicates status has not been verified in more than two years